Diabetic patient finds better control with open-source app, urges FDA reform

Living with type-1 diabetes for over thirty years, the author relied on FDA-cleared pumps and sensors that were periodically upgraded but eventually fell short of optimal control. Encouraged by a physician, they installed an open-source iPhone application that more precisely coordinates the sensor and pump, resulting in guideline-level glucose readings and a marked improvement in wellbeing. Acknowledging the risks of using software outside FDA supervision, the writer highlights the agency’s slow, device-centric review process and cites former FDA policy head Lowell Schiller on recent attempts to streamline low-risk applications.

The article discusses a pre-certification pilot launched under the prior administration and suggests that upcoming congressional reauthorization of FDA user fees could embed statutory reforms for medical software, including open-source tools. It warns that without such updates, patients may turn to home-grown solutions, creating an uneven landscape that disadvantages both users and regulated manufacturers. The author, Dana Goldman, concludes that modernizing oversight is essential to keep pace with rapid software innovation.